Interleukin 1 beta (IL-1β)
Interleukin 1-beta (IL-1β) is a pro-inflammatory cytokine secreted by monocytes and fixed tissue macrophages as a response to infection and other cellular injury. IL-1β mediated inflammatory response is implicated in the pathogenesis of rare genetic inflammatory diseases such as cryopyrin-associated periodic syndrome (CAPS) and acquired multifactorial autoimmune inflammatory disorders such as gouty arthritis, diabetes types II, asthma, and Sweet’s syndrome.
Several pharmacological agents have been developed to block IL-1β mediated signaling pathway including Anakinra, an interleukin-1 receptor antagonist, and Canakinumab, a monoclonal antibody against IL-1β. These agents have not only improved the treatment of the aforementioned diseases but also have helped understand the various physiologic roles of this pleiotropic cytokine. Various laboratory tests are available to determine the levels of IL-1β in the serum, saliva and other body fluids. The clinical significance of these tests is not well understood.
- Diagnosis of Cryopyrin-associated periodic syndrome
- As an aid in diagnosis of Diabetes type II
- As an aid in diagnosis of Gout
- As an aid in diagnosis of Reactive arthritis
- As an aid in diagnosis of Asthma and Chronic obstructive pulmonary disease (COPD)
- As an aid in diagnosis of psoriasis
Increased in:
- Cryopyrin-associated periodic syndrome
- Diabetes type II
- Gout
- Reactive arthritis
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Psoriasis
- Cystic fibrosis
- Pancreatitis
0-36 pg/mL
Serum (SST), plasma (EDTA).
Stability
- Ambient: not acceptable
- Refrigeration: not acceptable
- Frozen: up to 30 days
- Arthritis Rheum. 2011 Feb;63(2):314-24 [PMID: 20967858]
- Front Immunol. 2013 Oct 31;4:351 [PMID: 24198817]
- Clin Pharmacokinet. 2012 Jun 1;51(6):e1-18 [PMID: 22550964]
- Curr Allergy Asthma Rep. 2011 Oct;11(5):361-8. [PMID: 21728024]
- J Intern Med. 2011 Jan;269(1):16-28. [PMID: 21158974]